Inbar Nardi-Agmon

9PUBLICATIONS
18CO-AUTHORS
Molecular targetsCardiovascular medicine and haematology not elsewhere classifiedCancer diagnosisAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Feb 10, 2026
Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition and Cancer Risk: Insights from a Large Propensity-Matched Cohort Study.

Inbar Nardi Agmon, Chen Gurevitz, Tzippy Shochat

|Jan 30, 2026
Coronary atherosclerotic burden in patients with embolic stroke of undetermined source.

Yaron Aviv, Rani Barnea, Chen Gurevitz

|Apr 15, 2024
Complex left appendage morphology is associated with Embolic Stroke of Undetermined Source.

Inbar Nardi Agmon, Rani Barnea, Amos Levi

|Mar 20, 2024
Short- and long-term outcomes of patients with active cancer presenting with an acute coronary syndrome.

Inbar Nardi Agmon, Ori Rahat, Roy Beigel

|Jan 08, 2023
Albumin as a Prognostic Marker for Atrial Fibrillation Recurrence following Cryoballoon Ablation of Pulmonary Venous.

Nili Schamroth Pravda, Gregory Golovchiner, Gustavo Goldenberg

|Feb 15, 2022
The Potential Cardiotoxicity of Immune Checkpoint Inhibitors.

Inbar Nardi Agmon, Osnat Itzhaki Ben Zadok, Ran Kornowski

Pageof 2

Frequent Collaborators

3 joint publications

Ran Kornowski

2 joint publications

Ashraf Hamdan

2 joint publications

Rani Barnea

1 joint publications

Nili Schamroth Pravda